What's in the pipeline for pediatric headache treatment?
Headache: The Journal of Head and Face Pain · 2026-02 · 66 (2) · 548-550
DOI: 10.1111/head.70037 ↗At a glance
Journal article in Headache: The Journal of Head and Face Pain, published online on 2025-12-22. Written by Amy A Gelfand and 1 co-authors. Institution: Child & Adolescent Headache Program, Department of Neurology, University of California San Francisco, San Francisco, California, USA. Cited 3 times so far (Crossref); 9 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
calcitonin gene-related peptide, migraine, pediatricWhen the Childhood and Adolescent Migraine Prevention (CHAMP) trial was published in 2017, 1 it was as if a shadow fell over the landscape of pediatric headache."Nothing works in kids!" rang the lament.In all three treatment arms (topiramate vs. amitriptyline vs. placebo), approximately two-thirds achieved a ≥50% reduction in headache days.In truth, rather than showing that "nothing works" in children, CHAMP demonstrated that all three of these treatments worked for kids-at least for the two-thirds who got better.No doubt some of the improvement was due to placebo response.However, there were also careful co-interventions in CHAMP that likely contributed to participants' improvement: (1) giving a clear diagnosis of migraine; (2) providing evidence-based acute treatments (non-steroidal anti-inflammatory drugs [NSAIDs] and triptans); (3) regular counseling about sleep, exercise, hydration, and meals 2 ; and (4) counseling about the avoidance of medication overuse.3 Thus, CHAMP participants in all arms were actually given a number of interventions, which worked for many of them.None of the CHAMP participants received no treatment; therefore, providing no treatment is neither an evidence-based nor clinically acceptable approach to migraine prevention in children.
Subjects
Author keywords
Authors and institutions
- Child & Adolescent Headache Program, Department of Neurology, University of California San Francisco, San Francisco, California, USA.
- Children's Hospital of Philadelphia Pediatric Headache Program & Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID profiles: Amy A Gelfand
Cite
APA
Gelfand, A. A., & Szperka, C. L. (2026). What's in the pipeline for pediatric headache treatment?. Headache: The Journal of Head and Face Pain, 66(2), 548-550. https://doi.org/10.1111/head.70037
Vancouver
Gelfand AA, Szperka CL. What's in the pipeline for pediatric headache treatment?. Headache: The Journal of Head and Face Pain. 2026;66(2):548-550. doi:10.1111/head.70037
BibTeX
@article{Gelfand2026,
author = {Gelfand, Amy A and Szperka, Christina L},
title = {What's in the pipeline for pediatric headache treatment?},
journal = {Headache: The Journal of Head and Face Pain},
year = {2026},
volume = {66},
number = {2},
pages = {548--550},
doi = {10.1111/head.70037}
}
EUVIMED